Paper42801166PubMed
Promising Roles of Selenium Nanoparticles in Anti-Tuberculosis Therapy: Opportunities and Challenges.
Wang Y and 10 others. Int J Nanomedicine, 2026.
Cite this record
ConductScience Library. Promising Roles of Selenium Nanoparticles in Anti-Tuberculosis Therapy: Opportunities and Challenges. Papers, record 42801166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42801166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Promising Roles of Selenium Nanoparticles in Anti-Tuberculosis Therapy: Opportunities and Challenges.
- Journal
- Int J Nanomedicine
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-09-28
Source PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Selenium | Major topic |
| Tuberculosis | Major topic |
| Antitubercular Agents | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Animals | |
| Mycobacterium tuberculosis |
Source PubMed
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37570068 | A Review of the Antibacterial, Fungicidal and Antiviral Properties of Selenium Nanoparticles. | Materials (Basel) | 2023 | https://conductscience.org/library/papers/37570068 | PubMed |
| 2 | 35012958 | Drug resistant tuberculosis in Afghanistan: We must continue to put people at the centre of treatment. | BMJ | 2022 | https://conductscience.org/library/papers/35012958 | PubMed |
| 3 | 35250900 | Multi-Biofunctional Properties of Phytofabricated Selenium Nanoparticles From Carica papaya Fruit Extract: Antioxidant, Antimicrobial, Antimycotoxin, Anticancer, and Biocompatibility. | Front Microbiol | 2021 | https://conductscience.org/library/papers/35250900 | PubMed |
| 4 | 39453997 | Toxoplasma gondii macrophage migration inhibitory factor shows anti-Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction. | Sci Adv | 2024 | https://conductscience.org/library/papers/39453997 | PubMed |
| 5 | 37301074 | Selenium-mediated Cr(VI) reduction and SeNPs synthesis accelerated Bacillus cereus SES to remediate Cr contamination. | J Hazard Mater | 2023 | https://conductscience.org/library/papers/37301074 | PubMed |
| 6 | 37683341 | Multifaceted synergistic facilitation mechanism of conductive polymers in promoting selenite bioreduction and biological detoxification. | J Hazard Mater | 2023 | https://conductscience.org/library/papers/37683341 | PubMed |
| 7 | 39767013 | Immunoregulatory Effects of Codonopsis pilosula Polysaccharide Modified Selenium Nanoparticles on H22 Tumor-Bearing Mice. | Foods | 2024 | https://conductscience.org/library/papers/39767013 | PubMed |
| 8 | 38579586 | Multi-pathways-mediated mechanisms of selenite reduction and elemental selenium nanoparticles biogenesis in the yeast-like fungus Aureobasidium melanogenum I15. | J Hazard Mater | 2024 | https://conductscience.org/library/papers/38579586 | PubMed |
| 9 | 32583224 | Oxidative Stress and Trace Elements in Pulmonary Tuberculosis Patients During 6 Months Anti-tuberculosis Treatment. | Biol Trace Elem Res | 2021 | https://conductscience.org/library/papers/32583224 | PubMed |
| 10 | 35982253 | Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease. | Anal Bioanal Chem | 2022 | https://conductscience.org/library/papers/35982253 | PubMed |
| 11 | 37973334 | Tuberculosis and undernutrition in India. | Lancet Glob Health | 2023 | https://conductscience.org/library/papers/37973334 | PubMed |
| 12 | 34389421 | Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy. | Int J Pharm | 2021 | https://conductscience.org/library/papers/34389421 | PubMed |
| 13 | 37321739 | Nano-elemental selenium particle developed via supramolecular self-assembly of chondroitin sulfate A and Na2SeO3 to repair cartilage lesions. | Carbohydr Polym | 2023 | https://conductscience.org/library/papers/37321739 | PubMed |
| 14 | 39059357 | Diabetes mellitus-Progress and opportunities in the evolving epidemic. | Cell | 2024 | https://conductscience.org/library/papers/39059357 | PubMed |
| 15 | 38357443 | Editorial: The biological mechanism and health effect of co-infection with multiple pathogens. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38357443 | PubMed |
| 16 | 39261622 | Influence of smoking status on the relationship between serum selenium and cause-specific mortality in US adults. | Sci Rep | 2024 | https://conductscience.org/library/papers/39261622 | PubMed |
| 17 | 38086100 | Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review. | Talanta | 2024 | https://conductscience.org/library/papers/38086100 | PubMed |
| 18 | 37567200 | Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. | Lancet | 2023 | https://conductscience.org/library/papers/37567200 | PubMed |
| 19 | 39815246 | Size effect-based improved antioxidant activity of selenium nanoparticles regulating Anti-PI3K-mTOR and Ras-MEK pathways for treating spinal cord injury to avoid hormone shock-induced immunosuppression. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39815246 | PubMed |
| 20 | 34121366 | Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics. | Adv Healthc Mater | 2021 | https://conductscience.org/library/papers/34121366 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42875549 | Nanocarriers in psychiatry: a comprehensive review of emerging frontiers in the management of psychiatric disorders. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42875549 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42801166
GET https://conductscience.org/api/papers/v1/42801166/references?page=2